Avant Diagnostics, Inc. (OTC: AVDX) is a medical diagnostic technology company specializing in large panel biomarker screening. The company’s first test, OvaDx®, is being developed in conjunction with Arrayit Corporation (OTCQB: ARYC) as the market’s first large panel biomarker screening test for pre-symptomatic ovarian cancer. In preclinical research studies, OvaDx demonstrated high sensitivity and specificity […]
The Stocks To Buy Now Blog
Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.